Drug Shortage Report for CEFTAZIDIME FOR INJECTION BP
Report ID | 162207 |
Drug Identification Number | 02437848 |
Brand name | CEFTAZIDIME FOR INJECTION BP |
Common or Proper name | CEFTAZIDIME FOR INJECTION BP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFTAZIDIME |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 VIALS |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-06-03 |
Estimated end date | 2022-07-29 |
Actual end date | 2022-07-11 |
Shortage status | Resolved |
Updated date | 2022-07-12 |
Company comments | Fresenius Kabi is an alternate supplier of Ceftazidime for Injection. Fresenius Kabi is aware of our impending supply interruption and will have product available for SteriMax’s contracted customers. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-07-12 | English | Compare |
v4 | 2022-07-11 | French | Compare |
v3 | 2022-07-11 | English | Compare |
v2 | 2022-06-09 | French | Compare |
v1 | 2022-06-09 | English | Compare |
Showing 1 to 5 of 5